Alopecia is a hair loss condition leading to partial or complete baldness in individuals. The severity of hair loss may vary from a small area to the entire body. Alopecia occurs due to fungal infections, serious health problems, and unhealthy conditions confined to scalp. Alopecia drugs are medications that helps to treat and prevent hair loss. There are three types of alopecia drugs – topical, oral, and injectable available in the market. In addition, prevalence of alopecia is more in males as compared to females, as their body generates high levels of dihydrotestosterone (DHT), that shrinks’ hair follicles resulting in loss of hair.
The global alopecia drugs market is projected to reach a value of over US$ 10,000 Mn in 2026 at a CAGR of 4.8% over the forecast period.
The major factor driving growth of the global market is the rising preference for approved drugs among individuals across the globe. Increasing number of chemotherapy therapy procedures across the globe leading to hair loss in the individuals is expected to support growth of the target market. In addition, there is a rising demand for hair loss treatment drugs with enhanced effectiveness and minimal side effects which is another factor driving growth of the target market. Various combination of drugs is being tried by the healthcare professionals to increase the effectiveness of treatment for alopecia. However, high cost of several topical medications and patent expiry of many drugs are expected to hamper growth of the global market.
Development of drugs that can eliminate side effects caused by conventional alopecia drugs can create high potential revenue opportunity for target players in the global alopecia drugs market.
The global alopecia drugs market report has been segmented on the basis of route of administration, gender, and region. On the basis of route of administration, the global market is segmented into oral, injectable and topical. On the basis of region, the global alopecia drugs market is segmented into The Americas, Europe, Asia Pacific, and Rest of the World.
The market in North America is expected to account for highest market share in terms of revenue owing to government regulatory support for developing innovative drugs and increasing lifestyle changes such as physical inactivity and stress. The market in Europe holds the second highest share in terms of revenue owing to rising incidence of cancer patients and increasing penetration of advanced hair loss treatment therapies. The market in Asia Pacific is expected to be the fastest growing region in target market over the forecast period.
Request For The Sample Report Here: https://marketresearch.biz/report/alopecia-drugs-market/request-sample/
Key players profiled in the global alopecia drugs market include Taisho Pharmaceutical Holdings Co. Ltd., The Himalaya Drug Company, Johnson & Johnson Services, Inc., GlaxoSmithKline Plc., Cipla Inc., Dr. Reddy’s Laboratories Ltd., MERCK, Vitabiotics Ltd.
Table Of Content:
1.0 Chapter 1
- 1.1 Preface
- 1.2 Assumptions
- 1.3 Abbreviations
2.0 Chapter 2
- 2.1 Report Description
- 2.1.1 Market Definition and Scope
- 2.2 Executive Summary
- 2.2.1 Market Snapshot, By Route of Administration
- 2.2.2 Market Snapshot, By Gender
- 2.2.3 Market Snapshot, By Geography
3.0 Chapter 3
- 3.1 Global Alopecia Drugs Market Dynamics
- 3.1.1 Drivers
- 3.1.2 Restraints
- 3.1.3 Opportunities
- 3.1.4 PEST Analysis
- 3.1.5 PORTERS Analysis
4.0 Chapter 4
- 4.0.1 Global Alopecia Drugs Market Analysis, by Route of Administration
- 4.0.2 Overview
- 4.0.3 Segment Trends
- 4.0.4 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US $ Million)
- 4.1 Oral
- 4.1.1 Overview
- 4.1.2 Market Share and Forecast, and Y-o-Y Growth, 2016-2026, (US $ Million)